Prospective Evaluation of a Model of Prediction of Invasive Bacterial Infection Risk among Children with Cancer, Fever, and Neutropenia
Open Access
- 15 September 2002
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 35 (6) , 678-683
- https://doi.org/10.1086/342064
Abstract
A risk prediction model for invasive bacterial infection (IBI) was prospectively evaluated among children presenting with cancer, fever, and neutropenia. The model incorporated assessment of 5 previously identified risk factors: serum level of C-reactive protein (CRP) ⩾90 mg/L, hypotension, identification of relapse of leukemia as the cancer type, platelet count of ⩽50,000 platelets/mm3, and recent receipt of chemotherapy [16]. Children were uniformly evaluated at enrollment and were classified as having high or low risk for IBI according to a model that considers the number and type of variables present. Of the 263 febrile episodes evaluated during a 17-month period, 140 (53%) were in IBI-positive children. The sensitivity, specificity, and positive and negative predictive values of the model were 92%, 76%, 82%, and 90%, respectively. Identification of these 5 risk factors during the first 24 h of hospitalization was helpful in discriminating between children with a high or low risk for IBI.Keywords
This publication has 21 references indexed in Scilit:
- Neutropenia febril en el niño con cáncer: Conceptos actuales sobre criterios de riesgo y manejo selectivoRevista médica de Chile, 2001
- Oral versus Intravenous Empirical Antimicrobial Therapy for Fever in Patients with Granulocytopenia Who Are Receiving Cancer ChemotherapyNew England Journal of Medicine, 1999
- Fever and Neutropenia — How to Use a New Treatment StrategyNew England Journal of Medicine, 1999
- A Double-Blind Comparison of Empirical Oral and Intravenous Antibiotic Therapy for Low-Risk Febrile Patients with Neutropenia during Cancer ChemotherapyNew England Journal of Medicine, 1999
- A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studiesBritish Journal of Haematology, 1997
- Early Discharge of Low‐Risk Febrile Neutropenic Children and Adolescents with CancerClinical Infectious Diseases, 1997
- Discontinuation of Antimicrobial Therapy for Febrile, Neutropenic Children with Cancer: A Prospective StudyClinical Infectious Diseases, 1997
- Is it time to redefine the management of febrile neutropenia in cancer patients?The American Journal of Medicine, 1995
- The child with cancer and infection. I. Empiric therapy for fever and neutropenia, and preventive strategiesThe Journal of Pediatrics, 1991
- Duration of empiric antibiotic therapy in granulocytopenic patients with cancerThe American Journal of Medicine, 1979